Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esomeprazole for GERD-related Sleep Disturbances
NCT00660660Phase 4Completed
- Sponsor
- AstraZeneca
- Start
- Apr 2008
- Primary completion
- Jul 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in gastroesophageal reflux disease (GERD) comparing Nexium 20mg with Placebo (2 arms). Primary endpoint: Percentage of Patients With Relief of Nighttime Heartburn During the Last 7 Days of the Study at 4 weeks. Started Apr 2008; status: completed.
02
Drugs
esomeprazole
03
Conditions
gastroesophageal reflux disease (GERD)
Beyond the preview
Go deeper on NCT00660660.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00660660.